ASVRX
Price
$10.20
Change
+$0.09 (+0.89%)
Updated
Sep 11 closing price
Net Assets
2.77B
LVAQX
Price
$22.18
Change
+$0.12 (+0.54%)
Updated
Sep 11 closing price
Net Assets
701.71M
Interact to see
Advertisement

ASVRX vs LVAQX

ASVRX vs LVAQX Comparison Chart in %
View a ticker or compare two or three
VS
ASVRX vs. LVAQX commentary
Sep 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASVRX is a Hold and LVAQX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
ASVRX has more cash in the bank: 2.77B vs. LVAQX (702M). LVAQX pays higher dividends than ASVRX: LVAQX (1.35) vs ASVRX (0.42). ASVRX was incepted earlier than LVAQX: ASVRX (17 years) vs LVAQX (12 years). ASVRX (1.60) is less costly to investors than LVAQX (1.08). ASVRX is a more actively managed with annual turnover of: 42.00 vs. LVAQX (33.00). LVAQX has a lower initial minimum investment than ASVRX: LVAQX (1000) vs ASVRX (2500). LVAQX annual gain was more profitable for investors over the last year : 12.51 vs. ASVRX (0.25). LVAQX return over 5 years is better than : 46.26 vs. ASVRX (-2.93).
ASVRXLVAQXASVRX / LVAQX
Total Expense Ratio1.601.08148%
Annual Report Gross Expense Ratio1.601.08148%
Fund Existence17 years12 years-
Gain YTD18.95619.63197%
Front LoadN/AN/A-
Min. Initial Investment25001000250%
Min. Initial Investment IRAN/AN/A-
Net Assets2.77B702M394%
Annual Yield % from dividends0.421.3531%
Returns for 1 year0.2512.512%
Returns for 3 years13.4837.0336%
Returns for 5 years-2.9346.26-6%
Returns for 10 years29.4590.6033%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TRLCX27.88N/A
N/A
Nuveen Large Cap Value Retire
MAPOX117.58N/A
N/A
Mairs & Power Balanced
ETCHX49.94N/A
N/A
Eventide Healthcare & Life Sciences C
LHCVX23.97N/A
N/A
Lord Abbett Health Care R6
LFMGX28.77N/A
N/A
Lord Abbett Micro Cap Growth F